What is the role of antispasmodics (e.g. dicyclomine, hyoscyamine) in managing flatulence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Antispasmodics should not be used as a first-line treatment for managing flatulence, but may be considered for patients with irritable bowel syndrome (IBS) who experience abdominal pain and cramping, as suggested by the AGA clinical practice guideline 1. When considering the management of flatulence, it's essential to prioritize treatments that directly address gas production or expulsion. Lifestyle and dietary modifications are more effective first-line approaches, including:

  • Identifying and limiting gas-producing foods (such as beans, certain vegetables, and carbonated beverages)
  • Eating slowly
  • Avoiding gum chewing
  • Limiting lactose if intolerant Antispasmodics like dicyclomine and hyoscyamine work by relaxing smooth muscle in the gastrointestinal tract, which can help reduce abdominal pain and cramping associated with conditions like IBS, but they do not directly address gas production or expulsion. The AGA suggests using antispasmodics in patients with IBS, with a conditional recommendation and low certainty 1. Typical dosing includes dicyclomine 10-20 mg orally four times daily or hyoscyamine 0.125-0.25 mg orally every 4 hours as needed. However, side effects can include dry mouth, blurred vision, urinary retention, and constipation, which may actually worsen gas symptoms in some patients. The mechanism of action involves blocking acetylcholine at muscarinic receptors, reducing intestinal contractions and potentially providing relief from pain associated with gas distension, but without addressing the underlying cause of excessive gas production or retention.

From the FDA Drug Label

Dicyclomine relieves smooth muscle spasm of the gastrointestinal tract In controlled clinical trials involving over 100 patients who received drug, 82% of patients treated for functional bowel/irritable bowel syndrome with dicyclomine hydrochloride at initial doses of 160 mg daily (40 mg q.i.d.) demonstrated a favorable clinical response compared with 55% treated with placebo (p<. 05). Hyoscyamine sulfate inhibits gastrointestinal propulsive motility and decreases gastric acid secretion

The role of antispasmodics, such as dicyclomine and hyoscyamine, in managing flatulence is to relieve smooth muscle spasm of the gastrointestinal tract, which can help to reduce symptoms of irritable bowel syndrome and functional bowel disorders that may be associated with flatulence.

  • Dicyclomine has been shown to be effective in treating functional bowel/irritable bowel syndrome, with 82% of patients demonstrating a favorable clinical response in controlled clinical trials 2.
  • Hyoscyamine inhibits gastrointestinal propulsive motility and decreases gastric acid secretion, which may also help to alleviate symptoms of flatulence 3.

From the Research

Role of Antispasmodics in Flatulence Management

  • Antispasmodics, such as dicyclomine and hyoscyamine, are used to manage symptoms of irritable bowel syndrome (IBS), including abdominal pain and cramping 4.
  • A systematic review found that antispasmodics are effective in improving abdominal pain, global assessment, and symptom score in patients with IBS 5.
  • The review found that specific antispasmodics, such as cimetropium/dicyclomine, peppermint oil, pinaverium, and trimebutine, are effective in treating IBS symptoms 5.
  • Another study found that antispasmodics, such as dicyclomine and hyoscyamine, have not been proven effective in reducing abdominal pain in patients with IBS, but peppermint oil may be beneficial 6.
  • A more recent study found that a combination of chitin-glucan and simethicone (GASTRAP® DIRECT) is safe and well-tolerated, and alleviates IBS symptoms, including bloating and abdominal distension, rapidly in 2 weeks 7.
  • Expert practical guidance recommends the use of antispasmodics in the treatment of functional abdominal cramping pain (FACP), which may present with symptoms similar to IBS 8.

Mechanism of Action

  • Antispasmodics work by relaxing the muscles in the intestines, which can help to reduce abdominal pain and cramping 4.
  • Peppermint oil, a type of antispasmodic, may also have anti-inflammatory properties, which can help to reduce inflammation in the intestines 6.

Clinical Evidence

  • Clinical trials have shown that antispasmodics are effective in improving symptoms of IBS, including abdominal pain, bloating, and abdominal distension 5, 7.
  • A systematic review found that antispasmodics have a beneficial effect on IBS symptoms, with a number needed to treat (NNT) of 5-7 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Irritable Bowel Syndrome.

Current treatment options in gastroenterology, 1999

Research

Current gut-directed therapies for irritable bowel syndrome.

Current treatment options in gastroenterology, 2006

Research

Functional Abdominal Cramping Pain: Expert Practical Guidance.

Journal of clinical gastroenterology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.